Navigation Links
Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium
Date:9/9/2011

.nektar.com/">http://www.nektar.com.

Forward-Looking StatementsThis press release contains forward-looking statements that reflect management's current views regarding NKTR-102 and certain other drug candidates in Nektar's pipeline.  These forward-looking statements involve numerous risks and uncertainties, including but not limited to: (i) Nektar's product candidates and those of its collaboration partners are in various stages of clinical development and the risk of failure is high and can unexpectedly occur at any stage prior to regulatory approval for numerous reasons including safety and efficacy findings even after positive findings in preclinical and clinical studies; (ii) the timing of the commencement or end of clinical trials and the successful commercial launch of our drug candidates may be delayed or unsuccessful due to slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, regulatory delay, evolving regulatory requirements, clinical trial design, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulatory approval in one or more important markets; (iii) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of the application of Nektar's technology platform to potential new drug candidates is therefore highly uncertain and unpredictable and one or more research and development programs could fail; (iv) Nektar's patent applications for its proprietary or partner product candidates may not issue, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required in the future; (v) the outcome of any future intellectual property or other litigation related to Nektar's proprietary product candidates or complex commercial agreements; and (vi) certain other important risks and uncertainties set forth in Nektar's reports and other filings with the Sec
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... BERKELEY, Calif. and COPENHAGEN, ... CMC Biologics, Inc. , a global leader in clinical ... proteins, announced today that, as part of its global ... of its North American manufacturing facility in ... single-use Bioreactor 6Pack™ facility.  The Bioreactor 6Pack™ configuration consists ...
(Date:6/30/2015)... , June 30, 2015 ... as advisor to Chip-Man Technologies Oy (CMT) on its ... The assets relate to CMTs world leading capabilities in ... the latest in a series of successful global deals ... clients. Fintan Walton , CEO, PharmaVentures, ...
(Date:6/29/2015)... Diagnostics was honored at the 2015 IEEE Spectrum ... Award. IEEE President and CEO, Howard E. Michel , ... award to Principal Scientist Martina Medkova , Ph.D., on ... 2015, at the historic Waldorf Astoria hotel in ... spent more than 3 years as a Daktari scientist developing ...
Breaking Medicine Technology:CMC Biologics Expands GMP Manufacturing Capacity in the United States 2CMC Biologics Expands GMP Manufacturing Capacity in the United States 3PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2Daktari Honored with IEEE Spectrum Award 2
(Date:6/30/2015)... , ... June 30, 2015 , ... ... customers. As a subcontractor, ESSC ranked as one of their top 20 installing ... the last quarter of 2014. Providers are based on timeliness, service, installation, paperwork ...
(Date:6/30/2015)... ... , ... Ticket Down is a reliable source for cheap tickets for Journey at the ... band has been packing venues for years and they are one of the most beloved ... in their career. While Journey is known for their all-around great sound, fans of ...
(Date:6/30/2015)... ... June 30, 2015 , ... The board certified otolaryngologists ... design’ website to inform potential sinus surgery patients about ear, nose, and throat ... information about a wide variety of ENT issues including hearing loss, ear infections, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound ... Medicine Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, ... care and hyperbaric medicine education and training is something that is never complete. ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... YouTube video, “Fireside Convalescent Care Center.” The video informs community members of Fireside’s ... continually seeing the need for those seeking care to be well informed and ...
Breaking Medicine News(10 mins):Health News:Electronic Security Specialists (E.S.S.C. Inc) Awarded Top Service Provider Award By Monitronics 2Health News:Journey Tickets at The Stadium of Fire at Lavell Edwards Stadium in Provo, Utah: Ticket Down Slashes Ticket Prices for Journey on the 4th of July in Provo 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Fireside Convalescent Hospital Proves Itself as a Leading Care Center in New Video 2
... breast cancer patient has to pay thousands of dollars as ... case against the doctor//. Doctor Robert Newton is the family ... case for negligent treatment as they feel that the doctor ... case against Dr. Newton for a compensation of $2million for ...
... seen when Pharma major Wockhardt limited (Thiruvananthapuram) in association with ... vaccine//, marketed the latest vaccine for Hepatitis A. ,Hepatitis ... to be taken to curb the spread of the disease. ... period of almost a month and spreads to humans through ...
... arguments can delay wound healing according to a new study ... New Scientist//. ,.,Researchers at Ohio State University College of ... about half hour daily can have delayed wound healing at ... also cause reduced body immunity. ,42 married couples whose ...
... stabilize the rates of HIV by the year 2020 has ... HIV infected individuals on a monthly basis//. It has also ... below 0.3 percent by 2010. The current projected population of ... recent government decision, poor HIV carriers living in communities are ...
... Her-2/neu positive was helped by her Wangaratta community to ... costs her more than $70,000.// The fund was raised ... could help her to buy Herceptin drug for one ... to chemotherapy and anti-estrogen therapy such as tamoxifen and ...
... novel finding that love and addiction may go hand ... physiological effects manifested as a result of dopamine release// ... than a simulation of the effects observed following drug ... and drug abuse leaves the user with an insatiable ...
Cached Medicine News:Health News:‘Marriage Squabbles’ bad for both Emotional and Physical Wound 2Health News:Love And Drug Addiction Share The Same Chemistry 2
... Dermalinfusion is the only treatment ... a topical dermaceutical while exfoliating ... all skin types and addresses ... conditions including hyperpigmentation, acne, photodamage, ...
... practices that require an increased energy rating ... versatility of the Clareon System enables you ... that would typically require multiple cosmetic lasers. ... obsolescence because the Clareon is specifically designed ...
Disposable. Sterile Suction Tubing....
Bi-phasic peristaltic infusion pump for tumescent work....
Medicine Products: